[1] CHEN J J,HUANG S S,LI I F,et al.Prognostic association of demographic and clinical factors with the change rates of symptoms and depression among patients with hepatocellular carcinoma[J]. Support Care Cancer,2019,27(12):4665-4674.
[2] ZHAO Y,JIA Y,SHI T,et al.Depression promotes hepatocellular carcinoma progression through a glucocorticoids mediated up-regulation of PD-1 expression in tumor infiltrating NK cells[J]. Carcinogenesis,2019,40(9):1132-1141.
[3] JIA Y,LI F,LIU Y F,et al.Depression and cancer risk:a systematic review and meta-analysis[J]. Public Health,2017,149:138-148.
[4] LEE K T,LIN J J,SHI H Y.Anxiety and depression are associated with long-term outcomes of hepatocellular carcinoma:A nationwide study of a cohort from Taiwan[J]. World J Bio Psychiatry,2018,19(6):431-439.
[5] JIN S H,JUN T.Prevalence of anxiety and depression and their risk factors in Chinese cancer patients[J]. Support Care Cancer,2014,22(2):453-459.
[6] 赵凌云,韦珏伶,赵新华,等.巴塞罗那(BCLC)B/C期肝癌患者术前抑郁相关因素分析及对免疫功能的影响[J]. 现代肿瘤医学,2018,26(11):1727-1732.
[7] LINDEN W,VODERMAIER A,MACKENZIE R,et al.Anxiety and depression after cancer diagnosis:prevalence rates by cancer type,gender,and age[J]. J Affect Disord,2012,141(2-3):343-351.
[8] LABAKA A,GOÑI-BALENTZIAGA O,LEBEÑA A,et al.Biological sex differences in depression:a systematic review[J]. Biol Res Nurs,2018,20(4):383-392.
[9] FORERO C G,OLARIU E,ALVAREZ P,et al.Change in functioning outcomes as a predictor of the course of depression:a 12-month longitudinal study[J]. Qual Life Res,2018,27(8):2045-2056.
[10] WANG J,YAN C,FU A.A randomized clinical trial of comprehensive education and care program compared to basic care for reducing anxiety and depression and improving quality of life and survival in patients with hepatocellular carcinoma who underwent surgery[J]. Medicine,2019,98(44):e17552.
[11] 赵丹,余月菊.首诊中晚期肝癌患者治疗期间心理变化的影响因素分析[J]. 临床医学研究与实践,2019,4(5):108-109.
[12] 李桂花,任宇,徐峰.癌症抑郁共病的影响因素及药物治疗[J]. 上海医药,2018,39(22):9-11.
[13] CHEN V C,LIN C F,HSIEH Y H,et al.Hepatocellular carcinoma and antidepressants:a nationwide population-based study[J]. Oncotarget,2017,8(18):30464-30470.
[14] WANG Y,SHI YH,XU Z,et al.Efficacy and safety of Chinese herbal medicine for depression:a systematic review and meta-analysis of randomized controlled trials[J]. J Psychiatr Res, 2019,117:74-91.
[15] 迟洪亮,高振中,张致远,等.中药汤剂治疗肝癌相关性抑郁症的疗效观察[J]. 心理医生,2018,24(8):157-158.
[16] 朱建军,张磊,李艳.沈氏达郁汤加减方联合艾司西酞普兰对肝癌介入术后抑郁患者生活质量的影响[J]. 中西医结合肝病杂志,2017,27(4):217-219.
[17] RUBIN-FALCONE H,WEBER J,KISHON R,et al.Neural predictors and effects of cognitive behavioral therapy for depression:the role of emotional reactivity and regulation[J]. Psychol Med,2020,50(1):146-160.
[18] YE M,DU K,ZHOU J,et al.A meta-analysis of the efficacy of cognitive behavior therapy on quality of life and psychological health of breast cancer survivors and patients[J]. Psychooncology,2018,27(7):1695-1703.
[19] 沈君霞,余灵安 沈丹,等.认知行为疗法对肝癌晚期并发抑郁患者心理健康的影响[J]. 护士进修杂志,2016,31(11):975-977.
[20] MURPHY M J,NEWBY J M,BUTOW P,et al.iCanADAPT early protocol:randomised controlled trial (RCT) of clinician supervised transdiagnostic internet-delivered cognitive behaviour therapy (iCBT) for depression and/or anxiety in early stage cancer survivors treatment as usual[J]. BMC Cancer,2017,17(1):193.
[21] ANDERSSON G,CARLBRING P,ROZENTAL A.Response and remission rates in internet-based cognitive behavior therapy:an individual patient data meta-analysis[J]. Front Psychiatry,2019,10:749.
[22] 颜涵,徐翠荣,张斯秀.应用网络化认知行为疗法对癌症患者进行症状管理的Meta分析[J]. 中华现代护理杂志,2019,25(27):3438-3443.
[23] 周亮,郭志伟,母其文,等.rTMS治疗食管癌患者抑郁疗效的功能磁共振评估[J]. 西部医学,2019,31(4):614-619.
[24] TATEISHI H,NISHIHARA M,KAWAGUCHI A,et al.Improvement of frontal lobe dysfunction and white matter integrity by rTMS in treatment-resistant depression[J]. Neuropsych Dis Treat,2019,15:3079-3087
[25] WEI Y Y,ZHU J J,PAN S K,et al.Meta-analysis of the efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression[J]. Shanghai Arch Psychiatry,2017,29(6):328-342.
[26] SCHEINOST D,HOLMES S E,DELLAGIOIA N,et al.Multimodal investigation of network level effects using intrinsic functional connectivity,anatomical covariance,and structure-to-function correlations in unmedicated major depressive disorder[J]. Neuropsychopharmacology,2018,43(5):1119-1127.
[27] HONE-BLANCHET A,MONDINO M,FECTEAU S.Repetitive transcranial magnetic stimulation reduces anxiety symptoms,drug cravings,and elevates (1)H-MRS brain metabolites:a case report[J]. Brain Stimul,2017,10(4):856-858.
[28] KHEDR E M,KOTB H I,MOSTAFA M G,et al.Repetitive transcranial magnetic stimulation in neuropathic pain secondary to malignancy:a randomized clinical trial[J]. Eur J Pain,2015,19(4):519-527.
[29] NIZARD J,LEVESQUE A,DENIS N,et al.Interest of repetitive transcranial magnetic stimulation of the motor cortex in the management of refractory cancer pain in palliative care:two case reports[J]. Palliat Med,2015,29(6):564-568.
[30] BEN-HORIN I,KAHAN P,RYVO L,et al.Acupuncture and reflexology for chemotherapy-induced peripheral neuropathy in breast cancer[J]. Integr Cancer Ther,2017,16(3):258-262.
[31] 刘桂林.针灸配合磁珠贴耳穴治疗癌症患者抑郁失眠临床研究[J]. 亚太传统医药,2016,12(7):112-113.
[32] BOJORQUEZ G R,JACKSON K E,ANDREWS A K.Music thrapy for surgical patients:approach for managing pain and anxiety[J]. Crit Care Nurs Q,2020,43(1):81-85.
[33] GALLAGHER L M,LAGMAN R,RYBICKI L.Outcomes of music therapy interventions on symptom management in palliative medicine patients[J]. Am J Hosp Palliat,2017,35(1):250-257. |
